Sarcopenia - Drug Pipeline Landscape, 2022

Sarcopenia is a condition characterized by the loss of muscle mass and strength. It can occur due to a variety of reasons, including aging, inactivity, and certain chronic diseases.

Aging is the most common cause of sarcopenia. As people age, they tend to become less active and lose muscle mass. This process is known as age-related muscle loss or sarcopenia with aging.

Inactivity can also lead to sarcopenia. People who are not active tend to lose muscle mass and strength. This can be due to a sedentary lifestyle, bed rest, or prolonged immobilization.

To know more about Sarcopenia's pipeline, visit - https://www.globalinsightservices.com/reports/sarcopenia-drug-pipeline-landscape-2022/

Doctors most often diagnose sarcopenia after performing a physical exam and asking about symptoms. self-reported symptoms called the "SARC-F". The highest maximum SARC-F score is 10. A SARC-F score of 4 or more warrants more testing. The tests include handgrip test, Chair stand test, Walking speed test etc. Dual-energy X-ray absorptiometry (DEXA or DXA) is a type of imaging test uses low-energy X-rays to measure muscle mass, fat mass and bone density.

The main treatment path for sarcopenia is exercise. The most common investigative treatments include hormone replacement therapy which can help to raise lean body mass, decrease abdominal fat, and prevent bone deterioration in women whose hormone levels decrease with menopause and other treatment includes growth hormone supplements, testosterone supplements, hydroxy methyl butyrate, angiotensin converting enzyme inhibitors, vitamin D supplements.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS31120

Report Segmentation
Assessment by Stage of Development
Assessment by Companies
Assessment by Target
Assessment by Mechanism of Action
Assessment by Molecule Type
Assessment by Route of Administration

Key Players
• AAVogen Inc
• Anagenesis Biotechnologies SAS
• ARMGO Pharma Inc
• Bioleaders Corp
• Biophytis
• Dystrogen Therapeutics SA
• Elixir Pharma Co Ltd
• Encell Co Ltd
• Gerologix Inc
• ImmunoForge Inc.
• Keren Therapeutics
• Klotho Therapeutics Inc

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS31120

Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

For In-Depth Competitive Analysis, Purchase this Report - https://www.globalinsightservices.com/checkout/single_user/GIS31120

With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.

This release was published on openPR.